CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Galenica AG Company Snapshot
Galenica AG operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galenica AG with three other drug stores in Europe: Selcuk Ecza Deposu Ticaret ve Sanayi AS of Turkey (2015 sales of 7.48 billion Turkish Liras [US$2.01 billion] of which 100% was Medical and Hospital Equipment), Oriola KD Oyj of Finland (1.63 billion Euro [US$1.73 billion] of which 73% was Pharmaceutical Trade Sweden), and Pelion SA which is based in Poland (8.46 billion Polish New Zlotys [US$2.05 billion] of which 69% was Wholesale Trade).

Sales Analysis. Galenica AG reported sales of 3.79 billion Swiss Francs (US$3.76 billion) for the year ending December of 2015. This represents an increase of 11.0% versus 2014, when the company's sales were 3.42 billion Swiss Francs. Sales at Galenica AG have increased during each of the previous five years (and since 2010, sales have increased a total of 22%). Sales of Vifor Pharma saw an increase that was more than double the company's growth rate: sales were up 36.9% in 2015, from 706.20 million Swiss Francs to 967.02 million Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Galenica AG
  Stock Performance Chart for Galenica AG
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 1,139.00
(Figures in Swiss Francs)
1 Week -1.0%   13 Weeks 0.6%  
4 Weeks 10.0%   52 Weeks -14.4%  
 
Galenica AG Key Data:
  Ticker: GALN Country: Switzerland
  Exchanges: GVA OTH ZHR Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2015 Sales 3,791,586,000
(Year Ending Jan 2016).
Employees: 10,397
  Currency: Swiss Francs Market Cap: 7,371,333,501
  Fiscal Yr Ends: December Shares Outstanding: 6,471,759
  Share Type: Namenaktie Closely Held Shares: 2,528,523
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.